Viewing Study NCT07449234


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-04-05 @ 10:16 PM
Study NCT ID: NCT07449234
Status: RECRUITING
Last Update Posted: 2026-03-13
First Post: 2026-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
Sponsor: Janssen-Cilag Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module